CG Oncology, Inc. (CGON) Misses Q2 EPS by 30c
Tweet
Share
E-mailGet Alerts CGON Hot Sheet
Join SI Premium – FREE
CG Oncology, Inc. (NASDAQ: CGON) reported Q2 EPS of ($0.90), $0.30 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- General Dynamics wins $44.8M in defense contracts
- Deutsche Bank Starts Rhythm Pharmaceuticals (RYTM) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
